Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Open Access Gold |
|
as soon as is submitted to ZB.
Role and potential of different T helper cell subsets in adoptive cell therapy.
Cancers 15:18 (2023)
Historically, CD8+ T cells have been considered the most relevant effector cells involved in the immune response against tumors and have therefore been the focus of most cancer immunotherapy approaches. However, CD4+ T cells and their secreted factors also play a crucial role in the tumor microenvironment and can orchestrate both pro- and antitumoral immune responses. Depending on the cytokine milieu to which they are exposed, CD4+ T cells can differentiate into several phenotypically different subsets with very divergent effects on tumor progression. In this review, we provide an overview of the current knowledge about the role of the different T helper subsets in the immune system, with special emphasis on their implication in antitumoral immune responses. Furthermore, we also summarize therapeutic applications of each subset and its associated cytokines in the adoptive cell therapy of cancer.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.200
0.000
1
1
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Keywords
Cd4+ T Cell ; Adoptive Cell Therapy ; Cytokines ; Immunotherapy; Tumor-infiltrating Lymphocytes; Recombinant Human Interleukin-4; Th9 Cells; Th17 Cells; Antitumor Immunity; Dendritic Cells; Hepatocellular-carcinoma; Gene-therapy; Ifn-gamma; Tgf-beta
Language
english
Publication Year
2023
HGF-reported in Year
2023
ISSN (print) / ISBN
2072-6694
Journal
Cancers
Quellenangaben
Volume: 15,
Issue: 6,
Article Number: 18
Publisher
MDPI
Publishing Place
St Alban-anlage 66, Ch-4052 Basel, Switzerland
Reviewing status
Peer reviewed
Institute(s)
Unit for Clinical Pharmacology (KKG-EKLiP)
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Immune Response and Infection
PSP Element(s)
G-522100-001
WOS ID
000954205800001
Scopus ID
85151630978
PubMed ID
36980536
Erfassungsdatum
2023-10-06